Structure of gracillin
CAS No.: 19083-00-2
*Storage: {[sel_prStorage]}
*Shipping: {[sel_prShipping]}
The BI-3802 was designed by Boehringer Ingelheim and could be obtained free of charge through the Boehringer Ingelheim open innovation portal opnMe.com, associated with its negative control.
Gracillin is a kind of steroidal saponin isolated and purified from the roots of Dioscorea opposita Thunb. and the root bark of wild yam Dioscorea nipponica with antitumor agent.
Synonyms: NSC 698787
4.5
*For Research Use Only !
Change View
| Size | Price | VIP Price |
DE Stock US Stock |
Asia Stock Global Stock |
In Stock |
| {[ item.pr_size ]} |
Inquiry
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.discount_usd) ]} {[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} |
Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]} | {[ item.p_spot_brand_remark ]} 1-2 weeks {[ item.pr_usastock ]} In Stock Inquiry - | {[ item.p_spot_brand_remark ]} 1-2 weeks {[ item.pr_chinastock ]} {[ item.pr_remark ]} In Stock Inquiry - | Login - + |
Please Login or Create an Account to: See VIP prices and availability
Asia Stock: Ship in 3-5 business days
EU Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
{[ item.p_spot_brand_remark ]}
1-2weeks
Inquiry
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd,1,item.mem_rate,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ item.p_spot_brand_remark ]}
1-2weeks
Inquiry
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
In Stock
- +
Please Login or Create an Account to: See VIP prices and availability
Asia Stock: Ship in 3-5 business days
EU Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
| CAS No. : | 19083-00-2 |
| Formula : | C45H72O17 |
| M.W : | 885.04 |
| SMILES Code : | C[C@@]12[C@]([C@@H]3C)([H])[C@](O[C@]34CC[C@@H](C)CO4)([H])C[C@@]1([H])[C@@](CC=C5[C@@]6(CC[C@H](O[C@@](O[C@H](CO)[C@@H](O)[C@@H]7O[C@]([C@@H]([C@@H](O)[C@@H]8O)O)([H])O[C@@H]8CO)([H])[C@@H]7O[C@@](O[C@@H](C)[C@H](O)[C@H]9O)([H])[C@@H]9O)C5)C)([H])[C@]6([H])CC2 |
| Synonyms : |
NSC 698787
|
| MDL No. : | MFCD28978176 |
| GHS Pictogram: |
|
| Signal Word: | Warning |
| Hazard Statements: | H302-H315-H319-H335 |
| Precautionary Statements: | P261-P305+P351+P338 |
In Vitro:
|
Cell Line
|
Concentration | Treated Time | Description | References |
| A549 | 10 μM | 3 days | inhibited mitochondrial dehydrogenase activity and induced apoptosis | Cell Death Dis. 2019 Oct 24;10(11):810 |
| H460 | 10 μM | 3 days | inhibited mitochondrial dehydrogenase activity and induced apoptosis | Cell Death Dis. 2019 Oct 24;10(11):810 |
| PC9/ER | 10 μM | 3 days | inhibited mitochondrial dehydrogenase activity and induced apoptosis | Cell Death Dis. 2019 Oct 24;10(11):810 |
| PC9/GR | 10 μM | 3 days | inhibited mitochondrial dehydrogenase activity and induced apoptosis | Cell Death Dis. 2019 Oct 24;10(11):810 |
| DU145/R | 10 μM | 3 days | inhibited mitochondrial dehydrogenase activity and induced apoptosis | Cell Death Dis. 2019 Oct 24;10(11):810 |
| SK-MES-1/R | 10 μM | 3 days | inhibited mitochondrial dehydrogenase activity and induced apoptosis | Cell Death Dis. 2019 Oct 24;10(11):810 |
| H460/R | 10 μM | 3 days | inhibited mitochondrial dehydrogenase activity and induced apoptosis | Cell Death Dis. 2019 Oct 24;10(11):810 |
| H226B/R | 10 μM | 3 days | inhibited mitochondrial dehydrogenase activity and induced apoptosis | Cell Death Dis. 2019 Oct 24;10(11):810 |
| H1299 | 10 μM | 3 days | inhibited mitochondrial dehydrogenase activity and induced apoptosis | Cell Death Dis. 2019 Oct 24;10(11):810 |
| RBL-2H3 cells | 91.6 mg/g | 16 hours | To evaluate the effect of gracillin on IL-4 mRNA expression, results showed that DQEA significantly inhibited PMA/ionomycin-induced IL-4 mRNA expression | Nutrients. 2017 Dec 5;9(12):1324 |
| H9C2 cells | 5 μM and 20 μM | 24 hours | Gracillin could protect H9C2 cells from CoCl2-induced oxidative stress injury, increase SOD and LDH activities, and decrease MDA content. | Heliyon. 2023 Mar 9;9(3):e14353 |
| BEAS-2B cells | 0.25, 0.5, 1, 2, 4 μmol/L | 24 hours | To evaluate the antiproliferative activity of gracillin on BEAS-2B cells, the results showed that gracillin had almost no effect on the proliferation of BEAS-2B cells. | Front Oncol. 2022 Mar 22;12:851300 |
| A549 cells | 0.25, 0.5, 1, 2, 4 μmol/L | 24 hours | To evaluate the antiproliferative activity of gracillin on A549 cells, the results showed that gracillin significantly inhibited the cell viability of A549 in a concentration-dependent manner with an IC50 value of 2.421 mmol/L. | Front Oncol. 2022 Mar 22;12:851300 |
| SGC7901 cells | 0–15 μM | inhibited cell proliferation | Front Pharmacol. 2021 Sep 24;12:669199 | |
| BGC823 cells | 5 μM | 48 hours | inhibited cell proliferation, induced TIPE2 expression | Front Pharmacol. 2021 Sep 24;12:669199 |
| RBL-2H3 cells | 10 µM | 1 hour | To investigate the inhibitory effect of gracillin on IgE-mediated β-hexosaminidase release in RBL-2H3 cells. Results showed that gracillin significantly suppressed IgE-induced β-hexosaminidase release. | Nutrients. 2018 Sep 1;10(9):1205 |
| RBL-2H3 cells | 10 µM | 30 minutes | To investigate the inhibitory effect of gracillin on PI-induced IL-4 expression in RBL-2H3 cells. Results showed that gracillin significantly suppressed PI-induced IL-4 mRNA expression. | Nutrients. 2018 Sep 1;10(9):1205 |
| BEAS-2B cells | 0.25, 0.5, 1, 2, 4 μmol/L | 48 hours | Compared with the control group, gracillin had almost no effect on the viability of BEAS-2B cells. | Drug Des Devel Ther. 2021 Jan 20;15:233-243 |
| A549 cells | 0.25, 0.5, 1, 2, 4 μmol/L | 12, 24, 48 hours | Gracillin significantly inhibited the proliferation of A549 cells in a concentration-dependent and time-dependent manner with an IC50 value of 2.54 μmol/L and induced morphological changes. Flow cytometry analysis showed that the apoptosis rate of A549 cells was significantly increased (p < 0.05), and the cells were arrested in the S phase. The intracellular calcium concentration was elevated (p < 0.01), and the mitochondrial membrane potential was significantly decreased (p < 0.01). Additionally, the expression levels of Bax, caspase-3, cleaved caspase-3, and cytochrome C were dramatically up-regulated, while Bcl-2 was down-regulated (p < 0.05). | Drug Des Devel Ther. 2021 Jan 20;15:233-243 |
| MDA-MB-231 | 5 μM | 6 h | Inhibition of glycolysis, significantly reducing lactate production. | Cancers (Basel). 2020 Apr 8;12(4):913 |
| MDA-MB-468 | 5 μM | 6 h | Inhibition of glycolysis, significantly reducing lactate production. | Cancers (Basel). 2020 Apr 8;12(4):913 |
| H226B | 5 μM | 8 h | Inhibition of glycolysis-associated metabolites production, including 3-phosphoglycerate, phosphoenolpyruvate, pyruvate, and lactate. | Cancers (Basel). 2020 Apr 8;12(4):913 |
| H460 | 5 μM | 8 h | Inhibition of glycolysis-associated metabolites production, including 3-phosphoglycerate, phosphoenolpyruvate, pyruvate, and lactate. | Cancers (Basel). 2020 Apr 8;12(4):913 |
| BGC823/TIPE2−/− cells | 5 μM | 48 hours | inhibited cell proliferation, induced TIPE2 expression | Front Pharmacol. 2021 Sep 24;12:669199 |
| RKO | 0, 2.5, 5.0, 10.0 µmol/L | 36 hours | To evaluate the apoptosis-inducing effect of gracillin on human colorectal cancer cells. The results showed that gracillin stimulated apoptosis in RKO cells in a dose-dependent manner. | J Cell Mol Med. 2021 Jan;25(2):801-812 |
| HCT116 | 0, 2.5, 5.0, 10.0 µmol/L | 36 hours | To evaluate the apoptosis-inducing effect of gracillin on human colorectal cancer cells. The results showed that gracillin stimulated apoptosis in HCT116 cells in a dose-dependent manner. | J Cell Mol Med. 2021 Jan;25(2):801-812 |
| SW480 | 0, 2.5, 5.0, 10.0 µmol/L | 48 hours | To evaluate the inhibitory effect of gracillin on the proliferation of human colorectal cancer cells. The results showed that gracillin significantly inhibited the viability of SW480 cells with an IC50 value of 2.671 µmol/L. | J Cell Mol Med. 2021 Jan;25(2):801-812 |
| RKO | 0, 2.5, 5.0, 10.0 µmol/L | 48 hours | To evaluate the inhibitory effect of gracillin on the proliferation of human colorectal cancer cells. The results showed that gracillin significantly inhibited the viability of RKO cells with an IC50 value of 3.118 µmol/L. | J Cell Mol Med. 2021 Jan;25(2):801-812 |
| HCT116 | 0, 2.5, 5.0, 10.0 µmol/L | 48 hours | To evaluate the inhibitory effect of gracillin on the proliferation of human colorectal cancer cells. The results showed that gracillin significantly inhibited the viability of HCT116 cells with an IC50 value of 5.473 µmol/L. | J Cell Mol Med. 2021 Jan;25(2):801-812 |
In Vivo:
|
Species
|
Animal Model
|
Administration | Dosage | Frequency | Description | References |
| SKH-1 hairless mice | DNCB-induced AD-like skin lesions model | Topical application | 1% | Twice a day for 2 weeks | To investigate the therapeutic effect of gracillin on DNCB-induced AD-like skin lesions. Results showed that gracillin significantly improved AD-like skin symptoms, reduced epidermal thickening and mast cell infiltration, and improved skin barrier function. | Nutrients. 2018 Sep 1;10(9):1205 |
| NOD/SCID mice | MDA-MB-231 breast cancer cell line xenograft model | Subcutaneous injection | 20 mg/kg | Twice a week for 2 weeks | Gracillin significantly inhibited tumor growth without causing significant changes in body weight or other toxicities. | Cancers (Basel). 2020 Apr 8;12(4):913 |
| BALB/c nude mice | HCT116 xenograft model | Intraperitoneal injection | 1 mg/kg or 2 mg/kg | Every other day until the tumor volume reached ~100 mm^3 | To evaluate the inhibitory effect of gracillin on colorectal cancer tumor growth in vivo. The results showed that gracillin significantly inhibited tumor growth with no apparent physiological toxicity. | J Cell Mol Med. 2021 Jan;25(2):801-812 |
| BALB/c mice | A549 cell xenograft model | Intraperitoneal injection | High dose 20 mg/kg, medium dose 10 mg/kg, low dose 5 mg/kg | 6 days a week for two consecutive weeks | To evaluate the anti-tumor activity of gracillin in the A549 cell xenograft model, the results showed that gracillin significantly inhibited tumor growth in a dose-dependent manner. | Front Oncol. 2022 Mar 22;12:851300 |
| NOD/SCID mice | Xenograft models | Oral | 10 mg/kg | 6 days per week for 2 weeks | Significantly reduced the growth of xenograft tumors with no obvious toxicity | Cell Death Dis. 2019 Oct 24;10(11):810 |
| Bio Calculators | ||||
| Preparing Stock Solutions | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
1.13mL 0.23mL 0.11mL |
5.65mL 1.13mL 0.56mL |
11.30mL 2.26mL 1.13mL |
|
Tags: Gracillin | Apoptosis | Autophagy | inhibitor | 19083-00-2 |
Precautionary Statements-General | |
| Code | Phrase |
| P101 | If medical advice is needed,have product container or label at hand. |
| P102 | Keep out of reach of children. |
| P103 | Read label before use |
Prevention | |
| Code | Phrase |
| P201 | Obtain special instructions before use. |
| P202 | Do not handle until all safety precautions have been read and understood. |
| P210 | Keep away from heat/sparks/open flames/hot surfaces. - No smoking. |
| P211 | Do not spray on an open flame or other ignition source. |
| P220 | Keep/Store away from clothing/combustible materials. |
| P221 | Take any precaution to avoid mixing with combustibles |
| P222 | Do not allow contact with air. |
| P223 | Keep away from any possible contact with water, because of violent reaction and possible flash fire. |
| P230 | Keep wetted |
| P231 | Handle under inert gas. |
| P232 | Protect from moisture. |
| P233 | Keep container tightly closed. |
| P234 | Keep only in original container. |
| P235 | Keep cool |
| P240 | Ground/bond container and receiving equipment. |
| P241 | Use explosion-proof electrical/ventilating/lighting/equipment. |
| P242 | Use only non-sparking tools. |
| P243 | Take precautionary measures against static discharge. |
| P244 | Keep reduction valves free from grease and oil. |
| P250 | Do not subject to grinding/shock/friction. |
| P251 | Pressurized container: Do not pierce or burn, even after use. |
| P260 | Do not breathe dust/fume/gas/mist/vapours/spray. |
| P261 | Avoid breathing dust/fume/gas/mist/vapours/spray. |
| P262 | Do not get in eyes, on skin, or on clothing. |
| P263 | Avoid contact during pregnancy/while nursing. |
| P264 | Wash hands thoroughly after handling. |
| P265 | Wash skin thouroughly after handling. |
| P270 | Do not eat, drink or smoke when using this product. |
| P271 | Use only outdoors or in a well-ventilated area. |
| P272 | Contaminated work clothing should not be allowed out of the workplace. |
| P273 | Avoid release to the environment. |
| P280 | Wear protective gloves/protective clothing/eye protection/face protection. |
| P281 | Use personal protective equipment as required. |
| P282 | Wear cold insulating gloves/face shield/eye protection. |
| P283 | Wear fire/flame resistant/retardant clothing. |
| P284 | Wear respiratory protection. |
| P285 | In case of inadequate ventilation wear respiratory protection. |
| P231 + P232 | Handle under inert gas. Protect from moisture. |
| P235 + P410 | Keep cool. Protect from sunlight. |
Response | |
| Code | Phrase |
| P301 | IF SWALLOWED: |
| P304 | IF INHALED: |
| P305 | IF IN EYES: |
| P306 | IF ON CLOTHING: |
| P307 | IF exposed: |
| P308 | IF exposed or concerned: |
| P309 | IF exposed or if you feel unwell: |
| P310 | Immediately call a POISON CENTER or doctor/physician. |
| P311 | Call a POISON CENTER or doctor/physician. |
| P312 | Call a POISON CENTER or doctor/physician if you feel unwell. |
| P313 | Get medical advice/attention. |
| P314 | Get medical advice/attention if you feel unwell. |
| P315 | Get immediate medical advice/attention. |
| P320 | |
| P302 + P352 | IF ON SKIN: wash with plenty of soap and water. |
| P321 | |
| P322 | |
| P330 | Rinse mouth. |
| P331 | Do NOT induce vomiting. |
| P332 | IF SKIN irritation occurs: |
| P333 | If skin irritation or rash occurs: |
| P334 | Immerse in cool water/wrap n wet bandages. |
| P335 | Brush off loose particles from skin. |
| P336 | Thaw frosted parts with lukewarm water. Do not rub affected area. |
| P337 | If eye irritation persists: |
| P338 | Remove contact lenses, if present and easy to do. Continue rinsing. |
| P340 | Remove victim to fresh air and keep at rest in a position comfortable for breathing. |
| P341 | If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
| P342 | If experiencing respiratory symptoms: |
| P350 | Gently wash with plenty of soap and water. |
| P351 | Rinse cautiously with water for several minutes. |
| P352 | Wash with plenty of soap and water. |
| P353 | Rinse skin with water/shower. |
| P360 | Rinse immediately contaminated clothing and skin with plenty of water before removing clothes. |
| P361 | Remove/Take off immediately all contaminated clothing. |
| P362 | Take off contaminated clothing and wash before reuse. |
| P363 | Wash contaminated clothing before reuse. |
| P370 | In case of fire: |
| P371 | In case of major fire and large quantities: |
| P372 | Explosion risk in case of fire. |
| P373 | DO NOT fight fire when fire reaches explosives. |
| P374 | Fight fire with normal precautions from a reasonable distance. |
| P376 | Stop leak if safe to do so. Oxidising gases (section 2.4) 1 |
| P377 | Leaking gas fire: Do not extinguish, unless leak can be stopped safely. |
| P378 | |
| P380 | Evacuate area. |
| P381 | Eliminate all ignition sources if safe to do so. |
| P390 | Absorb spillage to prevent material damage. |
| P391 | Collect spillage. Hazardous to the aquatic environment |
| P301 + P310 | IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. |
| P301 + P312 | IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell. |
| P301 + P330 + P331 | IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. |
| P302 + P334 | IF ON SKIN: Immerse in cool water/wrap in wet bandages. |
| P302 + P350 | IF ON SKIN: Gently wash with plenty of soap and water. |
| P303 + P361 + P353 | IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower. |
| P304 + P312 | IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell. |
| P304 + P340 | IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing. |
| P304 + P341 | IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
| P305 + P351 + P338 | IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. |
| P306 + P360 | IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes. |
| P307 + P311 | IF exposed: call a POISON CENTER or doctor/physician. |
| P308 + P313 | IF exposed or concerned: Get medical advice/attention. |
| P309 + P311 | IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician. |
| P332 + P313 | IF SKIN irritation occurs: Get medical advice/attention. |
| P333 + P313 | IF SKIN irritation or rash occurs: Get medical advice/attention. |
| P335 + P334 | Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages. |
| P337 + P313 | IF eye irritation persists: Get medical advice/attention. |
| P342 + P311 | IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician. |
| P370 + P376 | In case of fire: Stop leak if safe to Do so. |
| P370 + P378 | In case of fire: |
| P370 + P380 | In case of fire: Evacuate area. |
| P370 + P380 + P375 | In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion. |
| P371 + P380 + P375 | In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion. |
Storage | |
| Code | Phrase |
| P401 | |
| P402 | Store in a dry place. |
| P403 | Store in a well-ventilated place. |
| P404 | Store in a closed container. |
| P405 | Store locked up. |
| P406 | Store in corrosive resistant/ container with a resistant inner liner. |
| P407 | Maintain air gap between stacks/pallets. |
| P410 | Protect from sunlight. |
| P411 | |
| P412 | Do not expose to temperatures exceeding 50 oC/ 122 oF. |
| P413 | |
| P420 | Store away from other materials. |
| P422 | |
| P402 + P404 | Store in a dry place. Store in a closed container. |
| P403 + P233 | Store in a well-ventilated place. Keep container tightly closed. |
| P403 + P235 | Store in a well-ventilated place. Keep cool. |
| P410 + P403 | Protect from sunlight. Store in a well-ventilated place. |
| P410 + P412 | Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF. |
| P411 + P235 | Keep cool. |
Disposal | |
| Code | Phrase |
| P501 | Dispose of contents/container to ... |
| P502 | Refer to manufacturer/supplier for information on recovery/recycling |
Physical hazards | |
| Code | Phrase |
| H200 | Unstable explosive |
| H201 | Explosive; mass explosion hazard |
| H202 | Explosive; severe projection hazard |
| H203 | Explosive; fire, blast or projection hazard |
| H204 | Fire or projection hazard |
| H205 | May mass explode in fire |
| H220 | Extremely flammable gas |
| H221 | Flammable gas |
| H222 | Extremely flammable aerosol |
| H223 | Flammable aerosol |
| H224 | Extremely flammable liquid and vapour |
| H225 | Highly flammable liquid and vapour |
| H226 | Flammable liquid and vapour |
| H227 | Combustible liquid |
| H228 | Flammable solid |
| H229 | Pressurized container: may burst if heated |
| H230 | May react explosively even in the absence of air |
| H231 | May react explosively even in the absence of air at elevated pressure and/or temperature |
| H240 | Heating may cause an explosion |
| H241 | Heating may cause a fire or explosion |
| H242 | Heating may cause a fire |
| H250 | Catches fire spontaneously if exposed to air |
| H251 | Self-heating; may catch fire |
| H252 | Self-heating in large quantities; may catch fire |
| H260 | In contact with water releases flammable gases which may ignite spontaneously |
| H261 | In contact with water releases flammable gas |
| H270 | May cause or intensify fire; oxidizer |
| H271 | May cause fire or explosion; strong oxidizer |
| H272 | May intensify fire; oxidizer |
| H280 | Contains gas under pressure; may explode if heated |
| H281 | Contains refrigerated gas; may cause cryogenic burns or injury |
| H290 | May be corrosive to metals |
Health hazards | |
| Code | Phrase |
| H300 | Fatal if swallowed |
| H301 | Toxic if swallowed |
| H302 | Harmful if swallowed |
| H303 | May be harmful if swallowed |
| H304 | May be fatal if swallowed and enters airways |
| H305 | May be harmful if swallowed and enters airways |
| H310 | Fatal in contact with skin |
| H311 | Toxic in contact with skin |
| H312 | Harmful in contact with skin |
| H313 | May be harmful in contact with skin |
| H314 | Causes severe skin burns and eye damage |
| H315 | Causes skin irritation |
| H316 | Causes mild skin irritation |
| H317 | May cause an allergic skin reaction |
| H318 | Causes serious eye damage |
| H319 | Causes serious eye irritation |
| H320 | Causes eye irritation |
| H330 | Fatal if inhaled |
| H331 | Toxic if inhaled |
| H332 | Harmful if inhaled |
| H333 | May be harmful if inhaled |
| H334 | May cause allergy or asthma symptoms or breathing difficulties if inhaled |
| H335 | May cause respiratory irritation |
| H336 | May cause drowsiness or dizziness |
| H340 | May cause genetic defects |
| H341 | Suspected of causing genetic defects |
| H350 | May cause cancer |
| H351 | Suspected of causing cancer |
| H360 | May damage fertility or the unborn child |
| H361 | Suspected of damaging fertility or the unborn child |
| H361d | Suspected of damaging the unborn child |
| H362 | May cause harm to breast-fed children |
| H370 | Causes damage to organs |
| H371 | May cause damage to organs |
| H372 | Causes damage to organs through prolonged or repeated exposure |
| H373 | May cause damage to organs through prolonged or repeated exposure |
Environmental hazards | |
| Code | Phrase |
| H400 | Very toxic to aquatic life |
| H401 | Toxic to aquatic life |
| H402 | Harmful to aquatic life |
| H410 | Very toxic to aquatic life with long-lasting effects |
| H411 | Toxic to aquatic life with long-lasting effects |
| H412 | Harmful to aquatic life with long-lasting effects |
| H413 | May cause long-lasting harmful effects to aquatic life |
| H420 | Harms public health and the environment by destroying ozone in the upper atmosphere |
Sorry,this product has been discontinued.
Home
* Country/Region
* Quantity Required :
* Cat. No.:
* CAS No :
* Product Name :
* Additional Information :
Total Compounds: mg
The concentration of the dissolution solution you need to prepare is mg/mL


